Precision Pharmacology
Therapeutic drug monitoring & clinical trial PK/PD support
ResearchActive
Key Facts
Indication
Therapeutic drug monitoring & clinical trial PK/PD support
Phase
Research
Status
Active
Company
About Adaptyx Biosciences
Adaptyx Biosciences is pioneering a novel class of continuous molecular monitoring devices. Its platform combines a minimally invasive wearable patch with programmable chemistry and AI analytics to stream biomarker data, targeting critical gaps in managing dynamic conditions like heart failure and chronic kidney disease. Founded in 2020 and built on over 17 years of Stanford research, the company is in the development and human feasibility study stage, backed by visionary investors. Adaptyx positions its technology as the future biochemical data backbone for AI-powered, personalized healthcare.
View full company profile